Editas Medicine Quarterly Balance Sheet
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Editas Medicine financial position
As of Sep 30, 2026, Editas Medicine reported total assets of $219.4 million, up 8.8% from a year earlier against total liabilities of $134.9 million. Shareholders' equity stood at $84.5 million, or 38.5% of assets. The company held $93.2 million in cash and equivalents against $56.8 million of debt, a net cash position of $36.3 million.
The current ratio (current assets divided by current liabilities) was 2.82, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.67.
Summary generated from market data by MetaCap's automated system. Methodology
Editas Medicine balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 93.17M | 181.81M | 123.65M | 146.65M | 165.65M | 138.54M | 138.69M | 131.54M | 95.83M | 64.44M | 69.23M | 123.65M |
| Short-Term Investments | 97.03M | 29.83M | — | 0 | 0 | 39.96M | 82.27M | 138.37M | 169.26M | 214.67M | 226.94M | 199.46M |
| Receivables | 7.73M | 2.73M | 2.59M | 15.18M | 8.13M | 588.00K | 510.00K | 16.27M | 126.00K | 244.00K | 245.00K | 10.19M |
| Total Current Assets | 201.97M | 218.07M | 128.07M | 163.90M | 176.89M | 182.80M | 224.84M | 289.31M | 271.14M | 286.35M | 305.56M | 340.83M |
| Property, Plant & Equipment | 2.19M | 2.57M | 2.88M | 3.54M | 4.29M | 4.58M | 8.18M | 14.50M | 15.42M | 14.16M | 13.26M | 12.03M |
| Long-Term Investments | — | — | — | — | — | — | — | 0 | 0 | 39.20M | 80.61M | 104.02M |
| Total Assets | 219.41M | 237.36M | 149.34M | 186.53M | 201.75M | 210.58M | 263.65M | 341.59M | 327.57M | 384.80M | 440.35M | 499.15M |
| Accounts Payable | 6.82M | 4.74M | 4.33M | 2.60M | 3.16M | 6.72M | 5.46M | 5.49M | 12.49M | 13.77M | 7.97M | 8.27M |
| Short-Term Debt | 7.50M | 7.50M | 7.50M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | — | — | — | 0 |
| Total Current Liabilities | 71.58M | 68.43M | 39.78M | 46.25M | 61.77M | 65.94M | 73.11M | 77.22M | 72.35M | 74.31M | 66.49M | 63.22M |
| Long-Term Debt | 49.32M | 48.24M | 47.18M | 53.60M | 54.07M | 51.67M | 49.58M | 52.43M | — | — | — | 0 |
| Total Liabilities | 134.89M | 132.08M | 144.93M | 159.25M | 188.30M | 191.39M | 201.23M | 207.31M | 151.93M | 152.79M | 145.95M | 150.06M |
| Shareholders' Equity | 84.52M | 105.28M | 4.41M | 27.29M | 13.45M | 19.19M | 62.42M | 134.27M | 175.63M | 232.01M | 294.40M | 349.10M |
| Retained Earnings | -1.70B | -1.67B | -1.65B | -1.63B | -1.62B | -1.60B | -1.54B | -1.47B | -1.42B | -1.36B | -1.29B | -1.23B |
| Total Debt | 56.82M | 55.74M | 54.68M | 58.60M | 59.07M | 56.67M | 54.58M | 57.43M | — | — | — | 0 |
| Net Cash (Debt) | 133.38M | 155.91M | 68.97M | 88.04M | 106.58M | 121.83M | 166.38M | 212.48M | 265.09M | 279.11M | 296.17M | 323.11M |
| Shares Outstanding | 97.87M | 97.87M | 97.87M | 97.87M | 93.26M | 87.39M | 83.71M | 82.73M | 82.54M | 82.43M | 82.23M | 81.77M |
This table shows 12 quarterly periods of Editas Medicine's balance sheet, from Q3 2026 back to Q4 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow EDIT's reporting calendar. What is a balance sheet?